Acarbose and Nitroglycerin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Acarbose (acarbose) and Nitroglycerin (nitroglycerin). Common drug interactions include constipation among females and pain among males.
The phase IV clinical study analyzes what interactions people have when they take Acarbose and Nitroglycerin. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.
What is Acarbose?
Acarbose has active ingredients of acarbose. It is often used in diabetes. eHealthMe is studying from 4,605 Acarbose users. Check the latest studies of Acarbose.
What is Nitroglycerin?
Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.
87 people who take Acarbose and Nitroglycerin together, and have interactions are studied.

What are the common drug interactions of Acarbose and Nitroglycerin, by gender? *:
female:
- Constipation
- Cardiomegaly (increased size of heart than normal)
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Discomfort
- Dizziness
- Mitral valve incompetence (inefficient heart valve)
- Nausea (feeling of having an urge to vomit)
- Tricuspid valve incompetence (inefficient heart valve)
- Abdominal pain upper
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
male:
- Pain
- Hyperlipidaemia (presence of excess lipids in the blood)
- Dyspnoea (difficult or laboured respiration)
- Gamma-glutamyltransferase increased
- Renal impairment (severely reduced kidney function)
- Blood alkaline phosphatase nos increased
- Dizziness
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Renal failure (kidney dysfunction)
- Cardiac failure
What are the common drug interactions of Acarbose and Nitroglycerin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Back pain
- Blood glucose decreased
- Hidradenitis (chronic disease of a type of sweat gland)
- Nephrolithiasis (calculi in the kidneys)
- Soft tissue neoplasm (tumour of soft tissue)
50-59:
- Pneumonia
- Renal failure (kidney dysfunction)
- Alanine aminotransferase increased
- Blood alkaline phosphatase nos increased
- Cellulitis (infection under the skin)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Gamma-glutamyltransferase increased
- Haematocrit decreased
- Haemoglobin decreased
- Hypertension (high blood pressure)
60+:
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Hypertension (high blood pressure)
- Urinary tract infection
- Constipation
- Melaena (the passage of black, tarry stools)
- Blood potassium increased
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Cardiomegaly (increased size of heart than normal)
- Diarrhoea
What are the existing conditions these people have? *
- High Blood Pressure: 15 people, 17.24%
- Cardiac Failure: 11 people, 12.64%
- Pain: 10 people, 11.49%
- Cardiac Failure Chronic: 10 people, 11.49%
- Type 2 Diabetes: 8 people, 9.20%
- Cardiac Disorder: 8 people, 9.20%
- Stress And Anxiety: 6 people, 6.90%
- Stable Angina (a constant chest pain): 5 people, 5.75%
- Rashes (redness): 5 people, 5.75%
- Itching: 5 people, 5.75%
* Approximation only. Some reports may have incomplete information.
Do you take Acarbose and Nitroglycerin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Acarbose (4,605 reports)
- Nitroglycerin (52,884 reports)
Browse all drug interactions of Acarbose and Nitroglycerin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Acarbose:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Nitroglycerin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Acarbose and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nitroglycerin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on acarbose and nitroglycerin (the active ingredients of Acarbose and Nitroglycerin, respectively), and Acarbose and Nitroglycerin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Carboplatin cause Vasospasm? - 10 seconds ago
- Could Mexiletine Hydrochloride cause Depression? - 11 seconds ago
- Drug interactions of Edarbi and Prednisone - 12 seconds ago
- Drug interactions of Pepcid and Stromectol - 12 seconds ago
- Could Loraz cause Rebound Effect? - 14 seconds ago
- Could Gliclazide cause Nephrotic Syndrome? - 21 seconds ago
- Parnate vs. Anafranil, side effect and effectiveness comparison - 27 seconds ago
- Could Amlodipine cause Coronary Heart Disease? - 31 seconds ago
- Could Lanoxin cause Dizziness? - 41 seconds ago
- Carac vs. Solaraze, side effect and effectiveness comparison - 43 seconds ago